MacuHealth upgrades its carotenoid supplement
Click Here to Manage Email Alerts
MacuHealth announced the launch of a new-and-improved carotenoid formulation eye supplement, MacuHealth with Micro-Micelle Technology.
The new product, which was commercially available July 22, enhances the stability and solubility of the components in MacuHealth’s 10-10-2 formula of lutein, zeaxanthin and meso-zeaxanthin with the addition of acetates, which incorporate the carotenoids into micromicelles, the company said in a press release.
As a result of this process, the gathering cells capture the carotenoids at a greater rate, leading to an improvement in absorption and bioavailability and an increase in carotenoid concentrations in the target issue.
MacuHealth with Micro-Micelle Technology was shown in a double-masked, placebo-controlled study to provide a higher serum response of lutein (+215%), zeaxanthin (+82%) and meso-zeaxanthin (+1,640%) when compared to the currently available product, MacuHealth President and Founder Frederic Jouhet, said in the release.
Study participants who received the upgraded supplement also exhibited statistically significant improvements in carotenoid concentrations in target tissue and skin carotenoid scores, the company said in the release.
“This is a very stable and highly bioavailable carotenoid formulation and represents a major scientific development that will empower eye care professionals across the world to support their patients with targeted nutrients of the eye, known as the macular carotenoids,” John Nolan, PhD, a professor at the Waterford Institute of Technology’s Nutrition Research Centre Ireland, said in the release. “This is essential for patients with, or at risk of, age-related macular degeneration, but also offers enormous potential to enhance vision for the general population, for every patient.”
Collapse
Read more about
Click Here to Manage Email Alerts